#Why Investing in Pfizer Stock (PFE) Is Worth It:
1. Fundamental Analysis (Fundamental)
Stock price: About 25.06$ (close to the annual low of $23.11).
Dividend yield: Excellent, reaching 7.11%, and it is currently the biggest driver for investors.
Valuation: The price-to-earnings multiple (18.46) is fair, and the stock trades at a discount of about 20% to its fair value (estimated at $30.82).
*Core takeaway: The stock is excellent as a source of passive income (dividends), but earnings growth is slow due to declining sales of COVID-related products and the current reliance on the success of newly acquired drugs.
2. Technical Analysis (Technical)
Trend: Bearish in the short and medium term (moving within a down channel and below moving averages).
Support and resistance levels:
Critical support: $23.11 (a break would be very bearish).
Resistance to confirm a rebound: $26.00 - $26.50$ (breaking above it would end the downtrend).
Relative Strength Index (RSI): Tends toward oversold, meaning the downward wave may be near its end, but there is no clear reversal signal yet.
Investment decision advice:
Long-term investor (dividend income): The current price is an excellent opportunity for gradual accumulation.
Trader (fast growth): Wait until the stock breaks the level of 26$ with strong trading volume to confirm the reversal of the downtrend.
#Dow_Jones #USstock #SAndP500